JEFFREY DANIEL EDELSON
Medical Practice in Berwyn, PA
License number
Pennsylvania MD070085L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Berwyn, PA 19312
Professional information
Method For Reducing Exacerbations Associated With Copd
US Patent:
2004000, Jan 8, 2004
Filed:
Jan 27, 2003
Appl. No.:
10/343078
Inventors:
Jeffrey Edelson - Berwyn PA, US
International Classification:
A61K031/00
US Classification:
514/001000
Abstract:
This invention relates to a method for reducing the incidences and/or the severity of exacerbations of COPD by administering a phosphodiesterase 4 (PDE4) inhibitor.
Uses Of Natriuretic Peptide Constructs
US Patent:
2013004, Feb 21, 2013
Filed:
Oct 17, 2012
Appl. No.:
13/653508
Inventors:
PALATIN TECHNOLOGIES, INC. - Cranbury NJ, US
Jennifer Lata - New Hope PA, US
Jeffrey D. Edelson - Berwyn PA, US
Jennifer Lata - New Hope PA, US
Jeffrey D. Edelson - Berwyn PA, US
Assignee:
PALATIN TECHNOLOGIES, INC. - Cranbury NJ
International Classification:
A61K 38/10, C07K 7/08, A61P 11/06, A61P 11/00
US Classification:
514 215, 530327
Abstract:
Use of constructs which bind to one or more natriuretic peptide receptors and include a plurality of amino acid residues and at least one amino acid surrogate of formula I:where R, R′, Q, Y, W, Z, J, x and n are as defined in the specification, and optionally at least one prosthetic group, for the prophylaxis or treatment of airway diseases, including but not limited to inflammation-related airway diseases, acute asthma or COPD, methods of prophylaxis and treatment of airway diseases and pharmaceutical compositions and formulations for the prophylaxis or treatment of airway diseases.
Method For Reducing Exacerbations Associated With Copd
US Patent:
2004021, Nov 4, 2004
Filed:
May 28, 2004
Appl. No.:
10/856460
Inventors:
Jeffrey Edelson - Berwyn PA, US
Assignee:
SmithKline Beecham Corporation
International Classification:
A61K038/43, C12N009/00
US Classification:
424/094100, 435/183000
Abstract:
This invention relates to a method for reducing the incidences and/or the severity of exacerbations of COPD by administering a phosphodiesterase 4 (PDE4) inhibitor.
Method For Reducing Exacerbations Associated With Copd
US Patent:
2006006, Mar 30, 2006
Filed:
Nov 16, 2005
Appl. No.:
11/280089
Inventors:
Jeffrey Edelson - Berwyn PA, US
International Classification:
A61K 31/277
US Classification:
514521000
Abstract:
This invention relates to a method for reducing the incidences and/or the severity of exacerbations of COPD by administering a phosphodiesterase 4 (PDE4) inhibitor.